BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

21 related articles for article (PubMed ID: 9494568)

  • 1. Estrogen and ERalpha: culprits in cervical cancer?
    Chung SH; Franceschi S; Lambert PF
    Trends Endocrinol Metab; 2010 Aug; 21(8):504-11. PubMed ID: 20456973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stimulation of c-myc oncogene expression associated with estrogen-induced proliferation of human breast cancer cells.
    Dubik D; Dembinski TC; Shiu RP
    Cancer Res; 1987 Dec; 47(24 Pt 1):6517-21. PubMed ID: 3677090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retinoic acid induces expression of the interleukin-1beta gene in cultured normal human mammary epithelial cells and in human breast carcinoma lines.
    Liu L; Gudas LJ
    J Cell Physiol; 2002 Nov; 193(2):244-52. PubMed ID: 12385002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcriptional regulation of vascular endothelial growth factor by estradiol and tamoxifen in breast cancer cells: a complex interplay between estrogen receptors alpha and beta.
    Buteau-Lozano H; Ancelin M; Lardeux B; Milanini J; Perrot-Applanat M
    Cancer Res; 2002 Sep; 62(17):4977-84. PubMed ID: 12208749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of retinoic acid on proliferation of estrogen-responsive transformed murine Leydig cells in serum-free culture.
    Hirose T; Koga M; Kouhara H; Kishimoto S; Matsumoto K; Sato B
    Cancer Res; 1990 Aug; 50(16):5060-4. PubMed ID: 2165854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retinoid antagonism of estrogen-responsive transforming growth factor alpha and pS2 gene expression in breast carcinoma cells.
    Fontana JA; Nervi C; Shao ZM; Jetten AM
    Cancer Res; 1992 Jul; 52(14):3938-45. PubMed ID: 1319834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of N-4-(hydroxycarbophenyl) retinamide as a cancer prevention agent and as a cancer chemotherapeutic agent.
    Han J; Jiao L; Lu Y; Sun Z; Gu QM; Scanlon KJ
    In Vivo; 1990; 4(3):153-60. PubMed ID: 2133256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological inactivation of MYC for the treatment of cancer.
    Felsher DW; Bradon N
    Drug News Perspect; 2003; 16(6):370-4. PubMed ID: 12973448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of tamoxifen and retinoic acid on cell growth and c-myc gene expression in human breast and cervical cancer cells.
    Tsai LC; Hung MW; Yuan CC; Chao PL; Jiang SY; Chang GG; Chang TC
    Anticancer Res; 1997; 17(6D):4557-62. PubMed ID: 9494568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genomic effects of tamoxifen.
    Kellen JA
    Anticancer Res; 1996; 16(6B):3537-41. PubMed ID: 9042218
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.